STOCK TITAN
  1. Home
  2. Sec-filings
  3. XOS
  4. [Form 4] Xos, Inc. Insider Trading Activity

Insider Sale: Emerald Green Trust Disposes of 7,922 XOS Shares Under 10b5-1 Plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Emerald Green Trust, identified as a reporting person for Xos, Inc. (XOS), reported a sale of 7,922 shares of XOS common stock on 09/12/2025 under a previously established Rule 10b5-1 trading plan. The reported weighted-average sale price was $2.3901, with individual sale prices ranging from $2.37 to $2.42. Following the reported sale, the filing shows the reporting person beneficially owns 1,574,212 shares of common stock as a direct owner. The filing was signed by Sarah Bardo, Trustee for Emerald Green Trust.

Positive

  • Sale executed under a Rule 10b5-1 trading plan, indicating pre-planned, non-discretionary transactions
  • Filing discloses weighted-average price and execution range ($2.37–$2.42), improving transparency
  • Reporting person retains a substantial position of 1,574,212 shares after the sale

Negative

  • None.

Insights

TL;DR: Insider sold a small stake under a Rule 10b5-1 plan; ownership remains substantial at 1.57M shares, so impact is limited.

The Form 4 discloses a routine sale of 7,922 shares executed on 09/12/2025 pursuant to a Rule 10b5-1 plan adopted 05/27/2025. The weighted-average price of $2.3901 and disclosed range ($2.37–$2.42) indicate orderly sales over that day or days. With 1,574,212 shares remaining beneficially owned directly, the sale represents a small fraction of the holder's position, suggesting limited immediate impact on control or voting power. The filing provides required transparency about the plan and price ranges, reducing informational asymmetry for investors.

TL;DR: Transaction appears procedurally compliant and pre-planned; disclosure of plan adoption date and price range is good governance practice.

The report identifies the sale as executed under a Rule 10b5-1 trading plan adopted by the reporting person on 05/27/2025, and it discloses the weighted-average price plus the range of execution prices. These elements align with best practices for insider trading transparency. The signature by the trustee is included. There is no indication of unusual timing or escalation in volume tied to corporate events in this filing alone. From a governance standpoint, the filing is complete and compliant with Section 16 reporting requirements.

Insider Emerald Green Trust
Role 10% Owner
Sold 7,922 shs ($19K)
Type Security Shares Price Value
Sale Common Stock 7,922 $2.3901 $19K
Holdings After Transaction: Common Stock — 1,574,212 shares (Direct)
Footnotes (1)
  1. The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025. Represents weighted average sales price. The shares were sold at prices ranging from $2.37 to $2.42. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Emerald Green Trust
(Last) (First) (Middle)
C/O XOS, INC.
3550 TYBURN STREET, UNIT 100
(Street)
LOS ANGELES CA 90065
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Xos, Inc. [ XOS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/12/2025 S 7,922(1) D $2.3901(2) 1,574,212 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025.
2. Represents weighted average sales price. The shares were sold at prices ranging from $2.37 to $2.42. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Remarks:
/s/ Sarah Bardo, Trustee for Emerald Green Trust 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Emerald Green Trust report selling in the XOS Form 4?

The trust reported selling 7,922 shares of Xos, Inc. common stock on 09/12/2025.

At what price were the XOS shares sold by Emerald Green Trust?

The filing reports a weighted-average sale price of $2.3901, with individual sales ranging from $2.37 to $2.42.

Was the sale by Emerald Green Trust part of a trading plan?

Yes. The transaction was effected pursuant to a previously established Rule 10b5-1 trading plan adopted on 05/27/2025.

How many XOS shares does Emerald Green Trust beneficially own after the sale?

The filing reports 1,574,212 shares beneficially owned following the transaction.

Who signed the Form 4 filing for Emerald Green Trust?

The Form 4 was signed by Sarah Bardo, Trustee for Emerald Green Trust on 09/15/2025.